Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 2/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.31 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.31 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.31 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15216282 | 0.85 | GABRA1 (0.32) | ACACBKMT2A | |
| SCHEMBL28296615 | 0.76 | KMT2A (0.41) | ACACBPIK3CDKMT2A | |
| SCHEMBL15216389 | 0.73 | HPGD (0.42) | KMT2A | |
| SCHEMBL26063407 | 0.73 | ACACB (0.34) | ACACBABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL26063410 | 0.73 | TP53 (0.34) | ACACBKMT2A | |
| SCHEMBL15216285 | 0.72 | KMT2A (0.32) | KMT2AABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL15216390 | 0.72 | ALDH1A1 (0.51) | KMT2A | |
| SCHEMBL26059443 | 0.70 | CA1 (0.39) | — | |
| SCHEMBL20013841 | 0.70 | ABCC9 (0.31) | KMT2AABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL7602472 | 0.70 | TSHR (0.46) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230280651-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-07 | — | — | US | disclosed |
| US-11693314-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230280651-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | EIF2B1, EIF2B5, EIF2B3 | ACACB 4022/4885PIK3CD 4372/4885KMT2A 2222/4885 |
| US-11693314-B2 | Resist composition and patterning process | EIF2B1, EIF2B5, EIF2B3 | ACACB 4022/4885PIK3CD 4372/4885KMT2A 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.